Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial
Bristol-Myers Squibb
Thomas Yau; Vittorina Zagonel; Armando Santoro; Mirelis Acosta-Rivera; Su Pin Choo; Ana Matilla; Aiwu Ruth He; Antonio Cubillo Gracian; Anthony B El-Khoueiry; Bruno Sangro; Tarek E Eldawy; Jordi Bruix; Giovanni Luca Frassineti; Gina M Vaccaro; Marina Tschaika; Christian Scheffold; Petra Koopmans; Jaclyn Neely; Fabio Piscaglia